Rituximab treatment in a child with rosai-dorfman disease and systemic lupus erythematosus

J Rheumatol. 2010 Aug 1;37(8):1783-4. doi: 10.3899/jrheum.091275.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents / therapeutic use*
  • Azathioprine / therapeutic use
  • Child
  • Drug Therapy, Combination
  • Histiocytosis, Sinus / complications
  • Histiocytosis, Sinus / diagnosis
  • Histiocytosis, Sinus / drug therapy*
  • Humans
  • Immunologic Factors / therapeutic use*
  • Immunosuppressive Agents / therapeutic use
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lymph Nodes / pathology
  • Lymph Nodes / surgery
  • Male
  • Methylprednisolone / therapeutic use
  • Prednisone / therapeutic use
  • Radiography, Thoracic
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Immunologic Factors
  • Immunosuppressive Agents
  • Rituximab
  • Azathioprine
  • Prednisone
  • Methylprednisolone